Levofloxacin
Product Images NDC 67296-0998

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Levofloxacin (NDC 67296-0998). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Epm Labels (67296 0998)

Epm Labels (67296 0998)
This is a description for Levofloxacin 750 mg tablets produced by Aurobindo Pharma Limited. The NDC numbers for the tablets are 67296-0998-1, 67296-0998-5, and 67296-0998-7. The tablets are for prescription use only, and come in packages of 10, 5, and 7 tablets. The usual adult dosage should be found in the package insert. The tablets should be stored at a controlled room temperature of 20-25°C (68-77°F). The manufacturer is Aurobindo Pharma Limited in Mahaboob Nagar, India, and the distributor is Redpharm Drug in Eden Prairie, MN 55344. The lot and expiration date for the tablets are provided on the packaging.*
FDA Label Image

Package Label-principal Display Panel (250 mg (50 Tablet Bottle))

Package Label-principal Display Panel (250 mg (50 Tablet Bottle))
Levofloxacin Tablets USP is a prescription medication that is taken once a day. Each tablet contains 250 mg of Levofioxacin USP. The usual adult dosage is indicated in the package insert. It is manufactured in India and distributed by Aurobindo Pharma USA, Inc. The medication guide should be given to each patient. It must be dispensed in well-closed, child-resistant containers and kept out of reach of children. It should be stored at a temperature between 20°C to 25°C (68°F to 77°F) and in the USP-controlled room. The provided text has a code and disclaimer for printing in the coding area, and the mentioned dotted lines should not be printed.*
FDA Label Image

Package Label-principal Display Panel (250 mg Blister Carton (10 x 10 Unit-dose))

Package Label-principal Display Panel (250 mg Blister Carton (10 x 10 Unit-dose))
This appears to be a description of a medication called Levofloxacin Tablets USP, with a recommended dosage for adults. The medication is apparently packaged in a unit-dose pack and must be kept in a child-resistant container out of the reach of children. The packaging contains 10 individually sealed tablets that are to be dispensed for outpatient use by a pharmacist, and an accompanying medication guide should be given to each patient. The medication is distributed by Aurabindo Pharma USA and manufactured in India.*
FDA Label Image

Package Label-principal Display Panel (500 mg (50 Tablet Bottle))

FDA Label Image

Package Label-principal Display Panel (500 mg Blister Carton (10 x 10 Unit-dose))

FDA Label Image

Package Label-principal Display Panel (750 mg (20 Tablet Bottle))

Package Label-principal Display Panel (750 mg (20 Tablet Bottle))
Each film-coated tablet contains 750mg of Levofloxacin USP. It is distributed by Aurobindo Pharma USA, Inc. and should be dispensed in a well-closed container. The usual adult dosage should be checked on the package insert. It should be dispensed in child-resistant containers and kept out of reach of children. The accompanying Medication Guide should be dispensed to each patient. There is an over printing zone and coding area on the packaging.*
FDA Label Image

Package Label-principal Display Panel (750 mg Blister Carton (10 x 10 Unit-dose))

FDA Label Image

Chemical Structure (Levofloxacin Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.